Cargando…
Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Disease
Symptomatic intracranial atherosclerotic disease (ICAD) is responsible for approximately 10% of all ischemic strokes in the United States. The risk of recurrent stroke may be as high as 35% in patient with critical stenosis >70% in diameter narrowing. Recent advances in medical and endovascular t...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Research Foundation
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040367/ https://www.ncbi.nlm.nih.gov/pubmed/21359195 http://dx.doi.org/10.3389/fneur.2010.00160 |